Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Swimming toward relief: water therapy tested for Parkinson's symptoms

NCT ID NCT07390825

Symptom relief Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether supervised pool exercises (aquatic therapy) can improve daily activities, walking, balance, posture, pain, and mood in people with Parkinson's disease. 42 participants will either do home exercises alone or add three 45-minute pool sessions per week for six weeks. The goal is to see if the water-based program leads to meaningful improvements in quality of life and movement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
aquatic therapy (pool exercises)
What this could lead to
If it works, this could point toward a simple, drug-free way to improve quality of life and mobility for people with Parkinson's.
What could go wrong
This is a small, early-stage trial (42 people) testing a non-drug intervention. Results may not apply to all Parkinson's patients, and the benefit over home exercise alone may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having a diagnosis of Idiopathic Parkinson's Disease between the ages of 40-80 and consenting to the treatment. * Being regularly followed by a neurologist and having a stable medical treatment regimen for at least 3 months. * Having a disease stage between 1-3 according to the Modified Hoehn-Yahr Staging Scale (MHY). * A score of 24 or higher on the Mini-Mental State Examination (MMSE). * Being able to verticalize independently and ambulate with or without assistance. Exclusion Criteria: * Having orthopedic, rheumatological, or non-Parkinson's neurological disorders that affect functional status. * Having a medical treatment regimen that has been modified within the last 3 months. * Presence of Atypical Parkinson's Disease. * Visual impairment. * Presence of dementia. * Decompensated cardiac or respiratory failure. * Diabetes insipidus. * Presence of systemic infection. * Impaired skin integrity or the presence of skin infections. * Increased sensitivity to inhaled steam or water chemicals. * History of epilepsy or asthma. * Urinary or fecal incontinence. * Refusal to participate in or consent to the treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bilkent City Hospital

    RECRUITING

    Çankaya, Ankara, 06800, Turkey (Türkiye)

  • Bilkent City Hospital

    RECRUITING

    Ankara, ÇANKAYA, 06800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.